Effects of Immulina TM Supplements With PASC Patients
Public ClinicalTrials.gov record NCT05524532. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effect of Immulina Supplements on Inflammatory Biomarkers Correlated With Clinical Symptoms in Patients With Long COVID (PASC)
Study identification
- NCT ID
- NCT05524532
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- University of Mississippi Medical Center
- Other
- Enrollment
- 101 participants
Conditions and interventions
Conditions
Interventions
- Immulina TM Drug
- Placebo Dietary Supplement
Drug · Dietary Supplement
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 19, 2023
- Primary completion
- Jul 28, 2025
- Completion
- Jul 28, 2025
- Last update posted
- Aug 13, 2025
2023 – 2025
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Hawaii | Honolulu | Hawaii | 96813 | — |
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808 | — |
| Louisiana State University | New Orleans | Louisiana | 70112 | — |
| MaineHealth | Portland | Maine | 04101 | — |
| University of Mississippi Medical Center | Jackson | Mississippi | 39216 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
| West Virginia University | Morgantown | Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05524532, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2025 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05524532 live on ClinicalTrials.gov.